Format

Send to

Choose Destination
Vaccine. 2008 Aug 19;26 Suppl 10:K68-75. doi: 10.1016/j.vaccine.2008.05.065.

Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia.

Author information

1
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. ams7@CDC.GOV

Abstract

Successful incorporation of a new vaccine into a nation's vaccination program requires addressing a number of issues, including: 1) establishing national recommendations; 2) assuring education of and acceptance by the public and medical community; 3) establishing and maintaining an appropriate infrastructure for vaccine delivery; 4) financing the vaccine and the program, in addition to political will. This article reviews the early experience with implementation of human papillomavirus (HPV) vaccination programs. It focuses on the United States of America and Canada and provides a brief report on Australia, where introduction is underway.

PMID:
18847559
DOI:
10.1016/j.vaccine.2008.05.065
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center